Source:http://linkedlifedata.com/resource/pubmed/id/19422601
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2009-5-8
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1399-5448
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
10
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
159-61
|
pubmed:meshHeading |
pubmed-meshheading:19422601-Blood Glucose,
pubmed-meshheading:19422601-Cystic Fibrosis,
pubmed-meshheading:19422601-Diabetes Mellitus, Type 1,
pubmed-meshheading:19422601-Diabetes Mellitus, Type 2,
pubmed-meshheading:19422601-Glucose Intolerance,
pubmed-meshheading:19422601-Glucose Tolerance Test,
pubmed-meshheading:19422601-Hyperglycemia,
pubmed-meshheading:19422601-Hypoglycemic Agents
|
pubmed:year |
2009
|
pubmed:articleTitle |
Abnormal glucose tolerance in CF--when should we offer diabetes treatment?
|
pubmed:publicationType |
Editorial
|